Research ArticleCancer

The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells

+ See all authors and affiliations

Sci. Signal.  06 Aug 2013:
Vol. 6, Issue 287, pp. ra66
DOI: 10.1126/scisignal.2004155

Article Information

vol. 6 no. 287 ra66

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • Received March 15, 2013
  • Accepted July 15, 2013

Author Information

  1. Aaron S. Meyer1,2,
  2. Miles A. Miller1,
  3. Frank B. Gertler2,3, and
  4. Douglas A. Lauffenburger1,2,3,*
  1. 1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  2. 2David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  3. 3Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  1. *Corresponding author. E-mail: lauffen{at}mit.edu

AltMetrics

Article usage

AbstractFullPDF
Aug 20133414355853
Sep 2013856216301
Oct 2013598105193
Nov 201339966130
Dec 20133243677
Jan 20142133177
Feb 20141954456
Mar 20141382541
Apr 20141061526
May 20141211527
Jun 20141141428
Jul 20141222319
Aug 20143092937
Sep 20141104242
Oct 2014794636
Nov 2014683431
Dec 2014592724
Jan 2015894626
Feb 20152834434
Mar 2015673131
Apr 2015874837
May 2015863226
Jun 2015893129
Jul 2015611432
Aug 201501523
Sep 201522914
Oct 201582016
Nov 201521426
Dec 201541526
Jan 201686713
Feb 2016831231
Mar 20161281020
Apr 201675820
May 201666514
Jun 20161691121
Jul 201695614
Aug 201699317
Sep 2016971118
Oct 20161801142
Nov 20161791143
Dec 20161951118
Jan 201711287
Feb 201786820
Mar 20171202119
Apr 2017921121
May 201786312

Related Content